Medvi: A Billion-Dollar Telehealth Venture
The story lands roughly two years after OpenAI CEO Sam Altman publicly predicted that AI would eventually enable a single person to build a billion-dollar company. Medvi, a GLP-1 telehealth provider founded by Matthew Gallagher, exemplifies this prediction with its rapid growth and innovative approach.
Since its inception in September 2024, Medvi has seen remarkable success, hitting $401 million in sales in 2025. The company is projected to reach an astounding $1.8 billion in sales in 2026, showcasing the effectiveness of Gallagher’s strategy that combines AI with strategic partnerships.
Gallagher launched Medvi with an initial investment of just $20,000 and utilized over a dozen AI tools, including ChatGPT, Claude, and Grok, to streamline operations. By the end of 2025, Medvi had amassed 250,000 customers and achieved a net profit margin of 16.2%.
In February 2026, Medvi expanded its offerings by launching a men’s health line, which quickly gained traction, attracting 50,000 customers in its first month. This rapid adoption highlights the increasing demand for telehealth services in specialized areas.
Matthew Gallagher remarked on the company’s growth, stating, “growth was insane.” His brother Elliot serves as the sole employee, underscoring the ultra-lean model that has become a hallmark of Medvi’s operations.
Industry observers have noted that Medvi’s success is a testament to the potential of AI in building scalable businesses. Jon Lensing commented, “Matthew’s native tongue seems to be A.I.,” while Fortune highlighted Medvi as “proof that AI is enabling ultra-lean, hyper-scalable companies.”
As Medvi continues to grow, the healthcare landscape may witness further shifts towards telehealth solutions, driven by technological advancements and changing consumer preferences. Sam Altman’s prediction appears to be materializing, with AI enabling entrepreneurs like Gallagher to redefine the boundaries of business.
With the healthcare sector increasingly embracing telehealth, Medvi’s trajectory will be closely monitored by industry analysts and competitors alike. The company’s innovative approach and impressive sales figures suggest that it may set new standards in the telehealth market.
Details remain unconfirmed regarding future expansions or additional product lines, but the current momentum indicates that Medvi is poised for continued success in the coming years.